EpCAM Antagonists Market Positive Long-Term Growth Outlook 2023

Global EpCAM Antagonists Market: Overview 

Epithelial cell adhesion molecule (EpCAM), is a cell surface protein or antigen, which is considered an highly expressed element in most of the key cancer types, including prostate, breast, colon, lung, gastric, ovarian, and pancreatic cancer. As a result, EpCAM antagonists are considered as well-established as an ideal therapeutic target and market for cancer of epithelial origin. The growing focus of leading players on research and development activities and technological advancements in the healthcare sector are projected to encourage the growth of the global EpCAM antagonists market throughout the forecast period.

Read the Comprehensive Overview of EpCAM Antagonists Market: http://www.transparencymarketresearch.com/epcam-antagonists-market.html

The research study offers a detailed analysis of the global EpCAM antagonists market, presenting insights into the important factors that are projected to impact the growth of the overall market in the near future. In addition, the driving factors, restraints, and the promising opportunities in the global EpCAM antagonists market have been highlighted in order to offer a strong understanding of the overall market. The product segmentation, innovations and developments, latest trends, major applications, key regional segments, and the competitive landscape of the global EpCAM antagonists market have been discussed in the research report.

Global EpCAM Antagonists Market: Drivers and Barriers 

The tremendously rising prevalence of different types of cancer across the globe is one of the key factors estimated to fuel the growth of the global EpCAM antagonists market throughout the forecast period. In addition, the rising government initiatives and spending on research and development activities for cancer treatment are expected to accelerate the growth of the overall market in the next few years. Furthermore, the constant development in the field of recombinant DNA technology is projected to offer promising opportunities for the key players operating in the global market for EpCAM antagonists.

However, the lack of awareness regarding the availability of advanced therapeutics, especially in developing economies and the high cost of overall cancer treatments are some of the key factors likely to restrict the growth of the global EpCAM antagonists market in the coming few years.

Global EpCAM Antagonists Market: Regional Outlook 

The global market for EpCAM antagonists can be classified in terms of geography to offer an in-depth analysis. The key regional segments include Asia Pacific, Europe, North America, and the Rest of the World. Among these, North America is projected to lead the overall market and account for a large share throughout the forecast period. The presence of a large number of leading players operating in this region is one of the major factors estimated to supplement the growth of the EpCAM antagonists market in the next few years.

Furthermore, the rising number of cancer cases in this region is another factor encouraging the growth of the market in the next few years. On the other hand, Asia Pacific is projected to witness significant growth in the coming years.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4678

Companies Mentioned in the Research Report 

Some of the key players operating in the EpCAM antagonists market across the globe are Johnson and Johnson, Amgen, Inc., Fresenius Biotech, The University of Hong Kong and American Association for Cancer Research, and Trion Pharma GmbH. The increasing number of players entering the global market and focusing on research and development activities are some of the factors estimated to accelerate the growth of the global EpCAM antagonists market throughout the forecast period.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Rising Incidence of Coagulation and Renal Disorders Increases the Demand for Europe Heparin Market

Europe Heparin Market: Snapshot

Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Hence, the demand for heparin in Europe is expected to increase in the next few years. The heparin market in Europe was valued at US$2.2 bn in 2015 and is projected to expand at a CAGR of 5.2% from 2016 to 2024 to reach US$3.5 bn in 2024.

Read the Comprehensive Overview of European Heparin Market: http://www.transparencymarketresearch.com/europe-heparin-market.html

Heparin Most Widely Used in Hospitals across Europe

Based on end user, the heparin market in Europe has been categorized into hospitals, blood and stem cell banks, and others. Hospitals and clinics widely use heparin as a blood thinner in the treatment of various diseases related to cardiovascular, cancer, and orthopedic. Heparin such as Calcilean, Calciparine, Hepalean, Heparin Leo, and Hepalean-lok are prominently used in hospitals for surgical purposes. The hospitals segment accounted for a major share of the heparin market in Europe as most surgical procedures are often performed in hospitals.

The blood and stem cell banks segment also held a significant share of the market in 2015. Blood and stem cell banks use heparin to collect cord blood and stem cells as heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.

Rapid Growth of Heparin Market Anticipated in Several European Nations

The heparin market in Europe has been segmented on the basis of geography into the following major markets: Germany, France, the U.K., Italy, Spain, Poland, Switzerland, Austria, Hungary, Belgium, Portugal, the Czech Republic, Greece, Slovakia, and Rest of Europe.

Germany accounted for the leading share in the heparin market in Europe in 2015 and is expected to continue its dominance till 2024. Key attributes to the market growth in Germany encompass burgeoning incidence of VTE among patients, resulting in the increased demand for heparin. Moreover, stringent regulations pertaining to Chinese active pharmaceutical ingredients (APIs) due to adulteration issues have attracted new players to the heparin processing and manufacturing business in Europe. Europe has been known to adhere to strict regulations pertaining to the import of heparin. For instance, in 2013, Germany-based meat company, Tönnies GmbH & Co, acquired Pharma Action, a heparin API manufacturer, and proposed to manufacture 30 metric tons of heparin API. Such developments are expected to augment the heparin market’s growth in Germany.

France, Belgium, and Portugal are anticipated to register the highest growth in the coming years. France also held the second position in the heparin market in Europe in 2015. Heparin consumption during and after surgical procedures such as knee replacement, hip surgery, appendectomy, and breast surgery is higher in France as compared to Italy, Spain, and the U.K. The increased risk of thrombosis among the geriatric population is also expected to drive the market for heparin in France.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4815

Major players in the Europe heparin market include Sanofi SA, Pfizer, Inc., Leo Pharma, Teva Pharmaceutical Industries Ltd, and Dr. Reddy’s Laboratories.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Advancements in Digital Infrastructure and Communication Technology Drives Teleradiology Market

Global Teleradiology Market: Snapshot 

The global teleradiology market is envisioned to boast a lucrative future, as foreseen by radiologic and research experts, in view of the fact that the evolution of sundry wireless technologies could allow continuous and accelerated image transfer.

Read the Comprehensive Overview of Teleradiology Market: http://www.transparencymarketresearch.com/teleradiology-technology-market.html

Worldwide institutions dealing with afterhours imaging services in different nations having different time zones while offering daytime reporting are anticipated to perk up the demand in the world teleradiology market. The significantly enhanced transmission speeds and Internet capacity coupled with swift advancements in digital image processing technologies could vastly benefit the world teleradiology market. Moreover, the telling surge in healthcare expenditure is envisaged to set the tone for the world teleradiology market.

The exorbitant cost of technology, paucity of imaging data security, and scarcity of adept technicians and radiologists could delay the growth in the world teleradiology market. Nonetheless, the world teleradiology market is expected to recover with the promotion in digital infrastructure. In 2016, the world teleradiology market had bagged in US$1.7 bn. However, by 2023, the world teleradiology market is envisaged to rake in US$3.6 bn at an 11.3% CAGR for the forecast period.

Computed Tomography Makes Statement as Groundbreaking Imaging Technology 

Computed tomography (CT) scan technology is foretold to register an overpowering revenue share of US$1.23 bn by the concluding forecast year and also a higher CAGR in the worldwide teleradiology market. CT scan is considered to be a revolutionary imaging technology which makes possible the visualization of complex bodily structures. With such a leading-edge technology in place compared to ultrasound and x-ray, there has been a perpetual improvisation in remote patient monitoring. This could effectively bolster the growth of the worldwide teleradiology market.

With a view to procure sophisticated healthcare informatics and image data using various angles, CT scan incorporates the engagement of x-rays. A multiplicity of teleradiology services and technologies could be widely accessed by patients with small and medium-sized healthcare organizations making available CT scan equipment.

Curbed exposure to radiation, non-invasive nature, and raised patient awareness are some of the aspects of ultrasound imaging predicted to place it second on the list of highest revenue earners by modality in the worldwide teleradiology market. Besides being a first line of gynecological disorder diagnosis, ultrasound imaging is critically employed to track fetal development and identify various abnormalities in a safe and secure manner.

Asia Pacific Towers over CAGR but North America Dominates Revenue 

Asia Pacific is prophesied to be amongst the highest CAGR getters by geography with 12.1% to talk for in the international teleradiology market. The growth of this regional teleradiology market could be accredited to the technological developments witnessed in Japan that are at par with the innovations of developed nations such as the U.S. and the U.K. Active government participation, approving healthcare policies, and expeditious technological advancements are prognosticated to testify for the roaring demand in the Asia Pacific teleradiology market. Australia, New Zealand, China, and India are predicted to be the other major Asia Pacific hubs for the teleradiology market.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1132

However, in terms of revenue, North America could win the race with an enormous share in the international teleradiology market. The U.S. teleradiology market is expected to stay dominant in North America throughout the forecast period. The evolution in the IT sector and innovation driven technological development could help the U.S. pull in a bumper revenue. On the other hand, Canada could be counting its fate on upcoming teleradiology service providers. Real Time Medical operating in the country was evaluated to hold one of the largest non-hospital based teleradiology services networks.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Rising Prevalence of HIV/AIDS and Hepatitis to Boost Antiviral Drugs Market

Global Antiviral Drugs Market: Overview 

In past 30 years, significant progress is seen in antiviral drugs market, mainly in case of the drugs that target the entry and escaping mechanisms of viruses, with an aim of improving the quality of patient’s life by introducing broad spectrum of combination therapy drugs. Viruses rely on host’s machinery for replication as well as metabolic activities, thus antiviral agents target these mechanisms by several inhibitor classes such as Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Fusion Inhibitors (FIs), Entry Inhibitors - CCR5 co-receptor antagonist, Protease Inhibitors (PIs), HIV Integrase strand transfer inhibitors, among others.

Read the Comprehensive Overview of Antiviral Drugs Market: http://www.transparencymarketresearch.com/antiviral-drugs-market.html

Demand for new and improved targeted therapies for viral diseases continues to rise, primarily due to invention of broad spectrum antiviral drugs. Introduction of combinational drug therapies with improved pharmacokinetic and pharmacodynamics properties, and focus on emerging regions for market penetration by creating awareness along with availability of affordable drugs are major opportunities for the global antiviral drugs market.

The market overview section of the report comprises qualitative analysis of the overall antiviral drugs market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis for the disease indications, product type, and distribution channels, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics. The prevalence HIV infection and HCV infection has also been provided, along with the FDA approvals and patent expiries of major drugs by each drug class. The pipeline analysis of major market players has been given in the market overview section.

Global Antiviral Drugs Market: Segmentation 

The global antiviral drugs market has been segmented on the basis of disease indication, product type, and distribution channels. On the basis of disease indication, the global antiviral drugs market is categorized as hepatitis virus infection, HIV infection, Respiratory virus infection, and others. In terms of product type, the global antiviral drugs market is divided into branded drugs, and generic drugs. Furthermore, on the basis of distribution channels, the global antiviral drugs market has been classified as hospital pharmacy store, retail pharmacy store, and online pharmacy.

The market for these disease indication, product type, and distribution channels has been extensively analyzed on the basis of factors such as drug usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (USD million) for each of these segments have been provided for the period 2014 to 2024, considering 2015 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2016 to 2024.

Geographically, the antiviral drugs market has been classified into five segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2014 to 2024, in terms of disease indication, product type, and distribution channels, along with the CAGR (%) for the forecast period 2016 to 2024.

Global Antiviral Drugs Market: Competitive Analysis 

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global antiviral drugs market, in terms of percentage share in 2016 (estimated) has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21083

The report concludes with the profiles of major players in the global antiviral drugs market such as AbbVie, Inc., Bristol-Myers Squibb Company, Cipla Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Mylan N.V., GlaxoSmithKline plc. Johnson & Johnson, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

North America Blood Collection Tubes Market is Estimated to Reach a Valuation of US$632.1 Mn by 2023

Blood collection tube is a plastic or glass tube that is without any infection or contamination. These tubes also have a closure, which is evacuated in order to build a vacuum in the interior of the tube, which in turn enables drawing an exact liquid volume from the patient. These tubes are primarily used to collect blood samples. However, they can also be used to collect urine samples as well as serum separator tubes. The North American market for blood collection tubes is gaining traction from a number of factors including the escalating demand from aging population for blood products and increasing number of complex surgical procedures.

Read the Comprehensive Overview of North America Blood Collection Tubes Market: http://www.transparencymarketresearch.com/north-america-blood-collection-tubes-market.html

The blood collection tubes market in North America was worth US$300.8 mn in 2014, which is estimated to reach a valuation of US$632.1 mn by 2023, expand at a robust CAGR of 8.6% during the forecast period of 2015 to 2023. The prosperity of this market can be attributed to the vast opportunities available for the players in the form of advanced screening tests, implementation of new blood collection techniques, and advent of automation in the process of collection of blood. These are some of the key factors anticipated to cater a significant demand in the North America market for blood collection tubes across North American countries such as the U.S. and Canada. On the other hand, stringent regulatory guidelines and healthcare policies will also reflect positively on the market during the forecast period as manufacturers are frequently coming up with new and safer technologies in order to collect blood. In addition to that, North America makes for a developed region, and thereby has high level of awareness among the consumers such as hospitals and diagnostic centers. This factor, as well as the subsidies offered by the government in the U.S. and Canada and advancements in blood collection technologies is expected to favor the market in a long-term.

Serum Separating Tubes In-Demand Segment

Based on product type, the global blood collection tubes market has been segmented into herapin tubes, plasma separation tube, EDTA tubes, serum separating tubes, rapid serum tubes, and others. Among these, the serum separating tubes segment accounted for 39.6% shares of the market in 2014, which was a result of utilization of diagnosis purposes across North America and utilization of diagnosis purposes across North America and increasing number of serum samples collected. Serum separating tubes utilize a particular gel that helps in separating blood cells from serum, and also contains particles that cause blood to clot easily. Serum is used to detect the presence of a particular antibody, antigen, hormone, and exogenous substances. Apart from that, the segment of rapid serum tubes is anticipated to increase at a higher rate during the forecast period, which is a result of advent of advanced technologies and incremented efficiency offered by the product.

The U.S. Most Lucrative Market by a Country-mile

The U.S. is the most lucrative country in the North America blood collection tubes market, accounting for 84.6% of the demand, which is primarily a reflection of increasing geriatric population along with the prevalence of various diseases. In addition to that, the increasing government initiatives in the country of the U.S. is expected to drive this market further. For example, introduction of patient protection affordable care act (PPACA) in March 2010 provides healthcare coverage to more than 94% of Americans. Canada is the second most profitable country in the North America blood collection tubes market.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8689

The North America blood collection tubes market is consolidated with a Becton Dickinson and Company being the pioneer and industry leader with 95% of the market in 2014. With a strong product portfolio of pre-analytical systems, BD is expected to maintain its stronghold in the near future. Terumo Corporation and Qiagen N.V. are some of the other prominent companies operating in this market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Ileostomy Market is Anticipated to Reach US$1.65 Bn by 2024 Expanding at a CAGR of 8.9%

Global Ileostomy Market: Snapshot

Ostomy is a surgical procedure which creates an opening in the human body to discharge body wastes. This opening which protrudes from the abdominal wall is called as the stoma. There are two ways ostomy is done, one is permanent and one is temporary. The ostomy procedure helps in the treatment of various diseases of urinary and digestive systems. The organs for ostomy are colon, rectum, bladder, and small intestine. Small Intestine is also called ileum.

Read the Comprehensive Overview of Ileostomy Market: http://www.transparencymarketresearch.com/ileostomy-market.html

In case of ileostomy stoma is created in small intestine (ileum) which bypasses colon, anus, and rectum. An appliance or bag is used to collect all the waste from ileum. Major applications of ileostomy are in the cases when the rectum or colon are not working properly due to diseases like colon cancer, rectal cancer, familial polyposis, inflammatory bowel disease (IBD), intestinal birth defects, intestinal accident, and intestinal emergency. Ileostomy procedure is carried out in the case of removal of whole or part of colon or large intestine. The global Ileostomy market was valued at US$765.2 mn in 2015 and is anticipated to reach US$1.65 bn by 2024, expanding at a CAGR of 8.9% from 2016 to 2024.

Patients to Continue Preferring Hospitals for Ileostomy

Based on procedure, the global ileostomy market is bifurcated into ileostomy and loop ileostomy. In loop ileostomy, ileum (small intestine) in pulled out through stoma, whereas, in end ileostomy colon and sometimes rectum is pulled out through stoma. Of the two segments, the end ileostomy accounted for the larger market share in 2015 and is expected to remain the dominant segment due to its rising application in the treatment of highly prevalent inflammatory bowel diseases. In fact, the segment is likely to showcase a higher CAGR during the forecast period.

Besides the aforementioned segments, the report covers the global ileostomy market based on end users such as ambulatory surgical centers, research centers, and hospitals. Of these, hospitals constituted the leading segment with a share of 55.2% in the global market in 2016. The segment is also prophesized to remain dominant through the forthcoming years, as patients will continue preferring hospitals due to the convenience of the organized set-up and availability of advanced procedures in hospitals. Furthermore, doctors and other therapeutic requirements are more easily accessible in hospitals, which make them more preferred among patients for surgical procedures. However, during the forecast period, the ambulatory surgical centers segment is expected to report a higher CAGR.

Based on equipment, the global ileostomy market is segmented into stoma bags, support belts & girdles, adhesive remover sprays, and protective stoma guards. Of these, stoma bags emerged dominant in the market in 2015. Among the segments based on disease condition type, the market was led by cancer in the same year.

Europe to Remain Dominant Regional Market; Asia Pacific to Report Higher CAGR

Regionally, the global ileostomy market is segmented into Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. Among these regions, Europe held the leading share of 43.2% of the global market in 2015. The region boasts a well-developed healthcare infrastructure, which had aided the expansion of the ileostomy market in Europe. Besides this, several leading companies are domiciled in Europe, who are also gaining from the region’s favorable healthcare policies. Spurred by these factors, Europe is expected to remain a lucrative market for ileostomy. However, during the course of the forecast period, Asia Pacific is expected to outperform Western countries in terms of CAGR.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23285

Major players operating in the ileostomy market includes Smith & Nephew, Convatec Inc., 3M Healthcare, B. Braun Melsungen AG, Coloplast, Hollister Incorporated, Salts Healthcare, Flexicare Medical Ltd., Marlen Manufacturing, and Pelican Healthcare.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Malaysia Medical Tourism Market is fueled by the Presence of Sophisticated Healthcare Infrastructure

The medical tourism industry in Malaysia is booming, which contributed to the fierce competition among the leading market players. Because the market is heading towards its maturity, a majority of the prominent enterprises are looking to offer dynamic changes in their services and products to keep reporting sustainable growth. Despite the presence of a large number of companies, the medical tourism market in Malaysia still exhibits a high degree of consolidation, with the leading players holding the crux of the market, finds Transparency Market Research (TMR) in a new report.

Read the Report Preview of Malaysia Medical Tourism Market: http://www.transparencymarketresearch.com/malaysia-medical-tourism-market.html

Some of the leading companies exhibiting a strong presence in the Malaysia medical tourism market are KPJ Healthcare Berhad, Prince Court Medical Centre, IJN Health Institute, Sunway Medical Centre, and Island Hospital. These institutions are focusing on emerging dominant by expanding their geographic footprint. Enhancing their foreign customer base has therefore become a key tactic for enterprises looking to establish a stronghold in the Malaysia medical tourism market.

According to TMR, the medical tourism market in Malaysia is forecast to expand a whopping 30.05% CAGR between 2016 and 2024. At this incredible pace, the market will reach US$3.5 bn by the end of 2024, from a valuation of US$424.96 mn in 2016.  Approximately 36.6% of medical tourists availed dental treatments in 2016, making it a leading market segment. Besides this, the market also witnessed considerably high demand in aesthetics/cosmetic surgery procedures and health screening segments.

Lucrative Government Incentives to Continue Bolstering Opportunities 

Low cost of medical services, compared to the same offered in developed economies of North America and Europe is the chief factor luring foreign medical tourists to Malaysia. Besides this, persistent government activities to boost the sector will synergize the country’s medical tourism industry. “With the rising influx of medical tourists from MENA and neighboring countries, the medical tourism market in Malaysia is poised to surge exponentially in the coming years,” said a lead TMR analyst.

The accelerated pace of gains witnessed in the medical tourism market in Malaysia is contributed by excellent macro-economic factors such as the increasing government programs promoting medical tourism, excellent transport facilities, and decent recuperation facilities. For instance, to boost medical tourism, the Malaysian government offers varied tax incentives, especially on the revenue generated from foreign patients. “In 2009, the government offered tax exemption of 50% on revenues earned from foreign patients, which was later increased to a whopping 100% by the end of 2010,” said a lead TMR analyst. Moreover, medical tourism is considered as one of the 12 national key economic areas (NKEAs) in Malaysia, which is a chief driver of the market.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20159

Medical Inflation Poses Threat to Market’s Growth

On the downside, medical inflation recorded in 2015 and a slight drop in the number of medical travelers could have an adverse influence on the market. Besides this, the market is already witnessing challenges from low revenue generated per patient, soaring healthcare costs, and the mounting burden on Malaysia’s healthcare system. Nevertheless, Malaysia is positioned as a preferred destination for medical travelers, which has potentiated the country’s medical tourism market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Propensity to Spend More on Companion Animals Fuels Veterinary Drugs Market

Global Veterinary Drugs Market: Snapshot

Across developed countries the ownership of companion or livestock animals of various known and exotic breeds has remained high since the last few decades. Developing countries are catching up in this regard as well. Across the world, livestock animals are majorly domesticated for their economic value. Dairy products, meat, fibers, and fertilizers derived from companion animals have considerable market value. In addition, their labor is put to use in agriculture and farming. Besides this, humans have grown fond of petting companion animals. Spurred by these factors the demand for veterinary drugs has increased as veterinarians and owners focus more on ensuring the health and wellness of companion pets.

Read the Report Preview of Veterinary Drugs Market: http://www.transparencymarketresearch.com/veterinary-drugs-market.html

While the market continues reeling under threat from the availability of low quality counterfeit products, the growing affordability of veterinary drugs will keep their demand pacing higher in the coming years. Given the scenario, Transparency Market Research (TMR) forecasts the market to exhibit a CAGR of 5.1% between 2016 and 2024. At this pace, the market which stood at US$17.2 bn in 2015, is forecast to reach US$26.7 bn by the end of 2024.

Demand for Veterinary Drugs to be Higher in Livestock Animals Segment

In terms of animal type, the global veterinary drugs market is bifurcated into companion animal and livestock animal. Of these, the livestock animal segment held the largest market share in 2015 on account of the high demand for high quality protein and poultry meat. The companion animal segment will exhibit robust growth as well during the course of the forecast period. The rising pet ownership and the increase in healthcare expenditure on them will boost this segment in the coming years.

Based on product, anti-infective, parasiticides, anti-inflammatory, and others comprise the key market segments. Of these, the anti-infective segment held the dominant share in the market in 2015 gaining from the increasing demand for zoonotic diseases. However, between 2016 and 2024, growth witnessed in the parasiticides segment is projected to be higher than other segments. It is forecast to exhibit a CAGR of 6.1% during the forecast period thereby emerging as the most lucrative product segment. The market will witness rising demand for anti-inflammatory drugs as well aimed at improving mobility and quality of life in companion animals.

North America to Continue Dominating Overall Market

Regionally, North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa constitute the key market segments. Among these, North America emerged dominant in 2015, accounting for value-based share of nearly 31%. It is expected to remain at the fore of the overall market through the course of the report’s forecast period. The region exhibits a higher prevalence of pet ownership as compared to other regions. In the same year, Europe emerged as the second-leading market segment. During the forecast period, Asia Pacific and Latin America is also expected to contribute to revenue generated by the overall market. The increasing incidence of infectious disease among animals will fuel the demand for effective veterinary drugs in Asia Pacific and Latin America.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21152

Some of the leading companies operating in the global veterinary drugs market are Zoetis, Inc., which dominated the overall vendor landscape in 2015, Boehringer Ingelheim GmbH, Bayer AG., Elanco Animal Health (Eli Lilly and Company), Ceva Santé Animale, Dechra Pharmaceuticals PLC., Merck & Co., Inc., Virbac, Vetoquinol, and others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Allergy-Relieving Eye Drops Market to Witness a Pronounce Growth by 2024

Itchy, red and watery eyes are the primary symptoms of allergy. Allergic eye is a very common ocular problem. The prevalence of the condition has been increasing over the years through environmental factors such as pollen, dust and pet dander. Approximately 2.7 percent of the several medical consultations across the globe are accounted for acute allergic diseases. Several kinds of allergic eye diseases have been identified which include seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis, atopic keratoconjunctivitis, atopic blepharoconjunctivitis, vernal keratoconjunctivitis, giant papillary conjunctivitis, and contact dermatitis.

Read the Report Preview of Allergy-Relieving Eye Drops Market: http://www.transparencymarketresearch.com/allergy-relieving-eye-drops-market.html

The key to treating eye allergies is to avoid or limit contact with the substance causing the problem. Rinsing out the eyes is the basic home remedy which can be immediately followed if eyes are itchy, red and burning. However, in some cases only rinsing out the eyes are not sufficient and allergies should be treated with eye drops, else occasionally severe eye allergies cause serious damage that can even threaten eyesight. This is the precise reason that the growth can be seen in eye drops market.

Allergy-relieving eye drops market: Segmentation and treatment

The global allergy-relieving eye drops market segmented on the basis of class into antihistamines, anti-inflammatory, decongestant, mast cell stabilizers and multiple action. Antihistamines include popular drugs such as emedastine difumarate, levocabastine and azelastine hydrochloride, while the anti-inflammatory class include Non-Steroidal Anti-Inflammatory Drugs (NSAID) and corticosteroids. The decongestant eye drops include naphazoline hydrochloric acid, tetrahydrozoline HCL phenylephrine HCL and oxymetazoline. Mast cell stabilizers such as ketotifen fumarate are available over-the-counter while other mast cell stabilizers require prescription and include pemirolast potassium, nedocromil sodium, lodoxamide and cromolyn.

The multiple action allergy relieving eye drops such as antihistamine/decongestant combination are also available. These products help to reduce redness, itching, watery eyes and blurriness.

Allergy-relieving eye drops market: Regions

On the basis of geography, the global allergy-relieving eye drops market is segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World. The global market was led by the North America region where the demand for these eye drops has always been maximum. Approximately, 54 million people that is about 20 percent of the U.S. population, have symptoms of allergies and almost half of these people have allergic eye diseases. Not only in U.S but the demand is also substantially rising in the regions of Asia-Pacific and few countries within the Latin America region. This would increase market share of these products in the region and help the global market to expand further.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14933

Allergy-relieving eye drops market: Key players

Some of the companies in the global allergy-relieving eye drops market include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc., Bausch & Lomb Inc., Cigna, and Similasan Corporation.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Concerns over Needlestick Injuries Spurs the Uptake of Diabetes Injection Pens Market

Global Diabetes Injection Pens Market: Overview

This report on diabetes injection pens market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of diabetes injection pens products such as insulin pen and pen needles as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global diabetes injection pens market with respect to the leading market segments based on major products segment, end users, and geographies.

Read the Report Overview of Diabetes Injection Pens Market: http://www.transparencymarketresearch.com/diabetes-injection-pens-market.html

Global Diabetes Injection Pens Market: Segmentation

Based on the product type, the diabetes injection pens market has been segmented into: insulin pen and pen needles. In term of diabetes injection pen usage products divided into reusable pens and disposable pens. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of diabetes incidences worldwide, technological advancement, and growing number of use of reusable pens in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Insulin Pens Show Continued Growth as Users Prefer it Over Pen Needles

On the basis of product, the global market is segmented into insulin pens and pen needles. Of these, the insulin pens are anticipated to assume the lead in the global market during the forecast period. By the end of 2024, the insulin pens segment is expected to acquire a share of 64.8%. The convenience of using insulin pens as compared to syringes and pumps is expected to drive their demand in the coming years. In terms geography, the global diabetes injection pens market is segmented into North America, Europe, Asia, Latin America, and Rest of the World. Currently, North America holds a dominating share in the global market due to a high degree of awareness about diabetes and its management. Asia Pacific is projected to grow at a steady rate during the forecast period due to a vast pool of patients that are expected to present a score of opportunities.

Global Diabetes Injection Pens Market: Drivers and Trends

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the diabetes injection pens market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global diabetes injection pens market.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8806

Key Players Mentioned in this Report are:

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global diabetes injection pens market. The report also profiles key players operating in the diabetes injection pens market which are Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Biocon Ltd., Sanofi S.A., Becton, Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co. and Wockhardt Ltd. The global diabetes injection pens market is dominated by three global vendors that accounts for more than 74% share of the global market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Rising Numbers of Open-heart Surgeries to Create Growth Opportunities for Surgical Sutures Market

Global Surgical Sutures Market: Overview

Surgical sutures or stitches are materials used to close a wound after a surgery or an injury. They are used to improve and speed the healing process. A suturing technique generally requires a needle in order to accomplish the process. Sutures have been and are the indispensable part of surgical procedures in almost all medical specialties. Surgical sutures are available in various sizes and configurations and are economical. Absorbable and non-absorbable are the two main types of sutures available in the market. The use of sutures depends on the body’s ability to absorb and degrade the suture material over time.

Read the Report Overview of Surgical Sutures Market: http://www.transparencymarketresearch.com/surgical-sutures-market.html

Absorbable sutures were introduced into the market some 40 years ago and were earlier made of biological materials such as catgut. Today synthetic absorbable sutures available in the market are made of polylactic acid, polyglycolic acid, polydioxanone and caprolactone. The report consists of an executive summary that provides information about the products, its segments along with a market snapshot and comparative analysis by geography, in terms of revenue %, for 2016.

Global Surgical Sutures Market: Scope and Research Methodology

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the surgical Sutures market, along with porter’s analysis, value chain analysis, of the global market, has been provided in this report. Market revenue analysis for all the above mentioned segments has been provided for the forecast period of 2017-2025, considering 2016 as the base year, and 2015 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2017-2025. Market share estimations were based on in-depth analysis and study of products, and their features etc.

This report provides in-depth analysis of the surgical sutures market. The stakeholders for this report include companies involved in the manufacturing of surgical sutures. Executive summary section is included snapshot on stakeholders in this report, which summarizes the market size, trends and competition in different regions. Market players and Market share analysis is analyzed to signify percentage share of the major players operating in the surgical sutures market. Furthermore, the report includes market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2016.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of key opinion leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.

Global Surgical Sutures Market: Segmentation Analysis

Based on product type, the surgical sutures market has been segmented into absorbable sutures and non-absorbable sutures. Absorbable sutures segment is growing at a CAGR of 2.8% from 2017 to 2025 due to it several advantages and application. Based on application, the surgical sutures are segmented into general surgeries, gynecological surgeries, cardiovascular surgeries, orthopedic surgeries, and other surgeries. The gynecological surgeries segment is expected to grow at a highest CAGR from 2017 to 2025. Based on end users, the market is segmented as hospitals, specialty clinics, and ambulatory surgery centers.

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Italy, Spain, rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, Saudi Arabia, South Africa, and Rest of Middle East & Africa.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=19172

Global Surgical Sutures Market: Competitive Insights 

The report also comprises list of major players in the market, their SWOT analysis, market share of these players in the Surgical Sutures market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, B. Braun Melsungen AG, Medtronic plc, Teleflex Incorporated, Johnson & Johnson, Smith & Nephew plc, Acelity L.P. Inc., Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., ConMed Corporation, and Integra LifeSciences Corporation.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

ePharmacy Market to Reach US$128.02 bn by 2023 Boosted by Greater Internet Penetration

Internet pharmacy or epharmacy is an online platform, which acts as an intermediate between the seller and consumer for the sale of medicines. ePharmacies are gaining popularity across the globe owing to the many benefits they offer, including easy access to complete information on prescribed drugs, low or discounted drug prices, and round-the-clock delivery of drugs. It is not necessary for the patients to be physically present at a store to buy required medicines, making ePharmacies a convenient option. The ePharmacies market is expected to grow rapidly due to the development of government regulations and ethical practices.

Read the Report Overview of ePharmacy Market: http://www.transparencymarketresearch.com/epharmacies-market.html

ePharmacies serve many needs such as easy access to medical records and easy availability of medicines in remote areas. Thanks to the development of ePharmacies, consumers can easily procure drugs via a tablet or smartphones. ePharmacies are a boon for patients who are seriously ill and need medicines urgently. However, the rising illegal sale of controlled prescription drugs is expected to hamper the growth of the global ePharmacy market in the years to come. Sales of medicines through ePharmacies can also lead to incidents of self-medication or drug abuse, which can be avoided with the integration of advanced technologies associated with drug delivery procedures.

Based on geography, the global epharmacy market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East. In 2014, in terms of revenue, the global epharmacy market was dominated by North America, followed by Europe. Europe is expected to be the fastest growing market in the global epharmacy market by 2023 due to factors such as the increasing penetration of high-speed internet and the increasing preference for buying medicines online. In the next few years, Asia Pacific is predicted to display lucrative growth due to the increasing spread of the e-commerce industry.

Some of the key players operating in the global epharmacy market are CanDrugstore.com, Lloyds Pharmacy Ltd., Domzdrowia.pl SA, Walgreen Co., Rowlands Pharmacy, CVS Caremark, PlanetRx.com, drugstore.com Inc., The SANICARE Group, eDrugstore.MD, and CanadaDrugs.com. The entry of new ePharmacies is expected to make the global ePharmacy market highly competitive in the years to come.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=397

From essentials to luxury products, everything is available on the internet via various retail platforms. The healthcare and medical sector are no exception. Over the past few years, there has been an increase in the number of people depending on online retail stores for their medicines. The increasing pool of people buying medicines from renowned epharmacies is expected to thus propel the global epharmacy market in the years to come.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Smart Syringes Market to Witness an Outstanding Growth by 2024

Smart Syringes Market: Overview

Smart syringes are gaining significant popularity around the world. These syringes are equipped with safety mechanisms, preventing their reutilization, and hence controlling unsafe injection practices.

Read the Comprehensive Overview of Smart Syringes Market: http://www.transparencymarketresearch.com/smart-syringes-market.html

In the recent times, the incidence of infections, owing to unsafe injection practices, has increased substantially. According to the WHO, around 1.7 million people were infected with the hepatitis B virus, almost 0.3 million were infected with hepatitis C virus, and approximately 34,000 individuals were reported to be infected with HIV due to unsafe injections in 2014. These cases, together with rising reports of needlestick injuries, have remarkably boosted the demand for smart syringes worldwide over the years.

This research report on the global market for smart syringes provides a comprehensive analysis of this market, taking its current as well as historical performance into consideration. Analysts have also predicted the future status of this market in this study by examining its future prospects and current and imminent major trends.

Smart Syringes Market: Key Trends and Opportunities

Smart syringes are generally utilized in vaccination, drug delivery, and blood specimen collection, among which drug delivery is the most common application area for these syringes. The prime end users of smart syringes are hospitals and health maintenance organizations (HMOs), psychiatrists, and diabetic patients. The demand for these syringes has been the highest from hospitals and HMOs over the last few years.

Auto-disabled (AD) syringes are attracting the highest demand among all the smart syringe products due to their single-use characteristic. These syringes find maximum application in the routine administration of medicines and fluids, owing to which the demand for them is likely to remain high over the next few years.

The passive safety syringes segment is also expected to gain significant impetus in the coming years. The ease of use, the improved patient safety ensured by the automated activation of the safety feature, and the efficient protection from the transmission of infections offered by these syringes are anticipated to fuel their demand in the future.

Smart Syringes Market: Region-wise Outlook

Geographically, the worldwide smart syringes market can be broadly segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. Currently, North America is leading the global market. Rising concerns about needlestick injuries, constant advancements in health-care practices, and the presence of a well-developed medical and health-care infrastructure in this region are driving the smart syringes market in North America.

Apart from this, Asia Pacific is likely to report a significant rise in its market share over the next few years. The rapid growth in disposable income has raised the level of health-care expenditure in this region. Awareness regarding safe injection practices is also rising. Several initiatives by the WHO and local governments to reduce needlestick injuries in order to curb various infections are projected to promote the usage of smart syringes in this region substantially in the near future. All these factors are expected to fuel the Asia Pacific smart syringes market in the coming years.

Smart Syringes Market: Competitive Outlook

Some of the leading participants in the global market for smart syringes are Smiths Group Plc, B. Braun Melsungen AG, Baxter International Inc., Terumo Medical Corp., Retractable Technologies Inc, Unilife Corp., Revolutions Medical Corp., Medtronic Plc (Covidien), and Becton, and Dickinson and Co.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12707

The high level of unmet needs in several emerging economies have provided market participants huge scope for growth. The growing trend of safe injection practices in medical and health-care systems globally is also presenting lucrative opportunities.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Artificial Pancreas Device Systems Market Poised to Expand at a Robust Pace Over 2024

Pancreas is a vital organ of the body, particularly the digestive system. It is a flat gland of about 6 inches, which is located in the abdomen and is surrounded by stomach, small intestine, liver, spleen, and gall bladder. It secrets several crucial hormones such as insulin and glucagon as well as enzymes for digestion and other metabolic processes in the body. Insulin lowers the blood sugar level of the body by enabling the cells to take up sugar in the form of glucose from the blood to produce energy. Glucagon helps in raising the blood sugar level by making the liver release stored glucose. The imbalance or improper functioning of these two hormones may lead to imbalance of the blood sugar level leading to diabetes.

Read the Comprehensive Overview of Artificial Pancreas Device Systems Market: http://www.transparencymarketresearch.com/artificial-pancreas-device-systems-market.html

Diabetes can be of four types: type I diabetes, type II diabetes, prediabetes, and gestational diabetes. In type I diabetes, no insulin is produced by the body. This accounts for approximately 10% of the total diabetes cases. In type II diabetes, insulin produced is insufficient to balance the blood sugar level. Prediabetes is a condition wherein the blood sugar level is high but is not sufficient to be called diabetes. In gestational diabetes, the blood sugar level is high in pregnant women.

The artificial pancreas device system, also referred to as closed-loop system, automated insulin delivery system, or autonomous system for glycemic control, is basically a system of devices coupled together to imitate the glucose regulation by a healthy pancreas. Artificial pancreas device system primarily consists of a continuous glucose monitoring (CGM) system, an insulin infusion pump, and a controlled algorithm. The CGM system constantly provides information about the patient’s blood glucose level. This is achieved by placing a sensor under the patient’s skin, which measures the glucose level in the interstitial fluid (fluid around cells). Thereby, both an evaluation of blood glucose level and their direction and rate of change of these evaluations are shown. Controlled algorithm is a software that can be installed on any device such as computer or cellular phone. It establishes constant communication between the CGM and the insulin pump. It collects the information from CGM and calculates it. On the basis of this information, the algorithm directs the insulin pump about the doses. The insulin infusion pump delivers insulin to the tissue under the skin in adequate doses as per the information received from the controlled algorithm.

Diabetes is a metabolic disorder. Unhealthy lifestyle, increasing trend of eating junk food and fast food, and lack of exercise are some of the factors leading to diabetes. These are also the factors driving the market for artificial pancreas device systems. Personal monitoring of insulin levels has shown improvement in the health of patients suffering from diabetes. Use of modern technologies, digitalization, and wireless and portable devices is likely to propel the artificial pancreas device systems market. However, constant maintenance and calibration of the glucose monitor, alteration in the efficiency of sensors caused by fibrosis (as sensors are placed subcutaneously) and the quality of insulin are some of the factors likely to hamper the artificial pancreas device systems market.

The artificial pancreas device systems market can be segmented into threshold suspend device systems, control to range systems (CTRS), and control to target systems (CTTS).

Based on the geographical region, the global artificial pancreas device systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market, with the increasing number of diabetes cases and growing awareness with the advancement in research and technology in the region. However, with the maximum increase in diabetes cases; India, China, Japan, Pakistan, the U.S., and Indonesia are expected to be potential markets for artificial pancreas device systems. Thus, Asia Pacific and North America are propelling the global market for artificial pancreas device systems. The market in Europe is also likely to witness growth with the increasing awareness in the region.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19370

Some players operating in the global artificial pancreas device systems market are Medtronic, Johnson & Johnson, Beta Bionics, Pancreum, LLC, and JDRF.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Healthcare Cloud Computing Market is Driven by Rising Demand for Stringent Regulatory Compliance

Cloud computing is one of the most commonly used applications in healthcare. Healthcare organizations are highly concerned about the privacy and security of patient information, and the pressure of managing the growing healthcare data has driven the implementation of cost effective solutions such as cloud computing. Therefore, healthcare companies are accepting cloud computing as an effective solution for data storage. This technology provides various benefits such as business agility, privacy & security, reduced cost and so on. Increasing utilization of information technology in the healthcare industry has led to rising adoption of cloud computing by the global healthcare cloud computing industry. However, this market faces major challenges such as high initial investment and shortage of skilled work force. Adoption of cloud computing by healthcare providers is projected to significantly rise. Polycom, a U.S-based company that produces video conferencing equipment, provides cloud-based on-demand video conferencing solutions which helps to decrease on-premise infrastructure costs. Cloud solutions for strong and retrieving data are expected to reduce IT expenditure in healthcare institutions.

Read the Comprehensive Overview of Healthcare Cloud Computing Market: http://www.transparencymarketresearch.com/healthcare-cloud-computing-market.html

The global healthcare  cloud computing market is expected to expand substantially due to implementation of favorable regulatory acts, growing investment from healthcare players, proliferation of high speed internet, government organizations, public awareness, rising demand for stringent regulatory compliance, new payment models, and the implementation of the Patient Protection and Affordable Care Act. The restraining factors for the global healthcare cloud computing market are issues related to data privacy, rising number of cloud data breaches, and data portability complications. There are opportunities in global healthcare cloud computing market to development responsible care organizations to increase scope for healthcare cloud computing and Telecloud to create opportunities for healthcare cloud computing market. Increase of cloud computing solution for telemedicine is current trend for this market.

The global healthcare cloud computing market is segmented by service, cloud deployment model, application, end user, and by region. By service, the market is divided into platform as a service, infrastructure as a service, and software as a service. On the basis of cloud deployment model, the market is segregated into public, private, and virtual private cloud. By application, the market is further categorized into clinical information system and non-clinical information system. Clinical information system includes pharmacy information system, computerized physician order entry, radiology information system, electronic medical records and others. Non-clinical information system covers revenue cycle management, automatic patient billing, claim management and others. Based on end- user application, the market is classified into healthcare payers and healthcare providers. Non-clinical information system is the dominant segment in the global healthcare cloud computing market. In clinical information system, electronic medical record system is the dominant segment.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25517

The key players operating in the healthcare cloud computing market include IBM Corporation, Microsoft Corporation, CareCloud Corporation, Carestream Health, Inc., Athenahealth, Inc., Cisco Systems, Inc.  ClearData Networks, Inc., EMC Corporation, Dell, Inc.,  Iron Mountain, Inc., Hewlett-Packard Company, IncMerge Healthcare, Inc., Oracle Corporation and VMware, Inc. In order to gain competitive advantage in the industry, key players are actively involved in providing variation to products and services, and also indulging in continuous new product launches. Collaborations, partnerships, and agreements are some of the important strategies followed by market players to stay ahead of the competition.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Advanced Technologies for Drugs Administration Supports the Growth of CINV Treatment Market

According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience chemotherapy-induced nausea and vomiting (CINV). CINV can be categorized into 4 types - Acute emesis - patient experiencing nausea and vomiting within 24 hours, Delayed emesis - patient experiencing nausea and vomiting after 24 hours of chemotherapy, Anticipatory emesis - occurs in future chemotherapy cycles as a response to the adverse memory of previous treatments. Breakthrough emesis and refractory emesis - occurs in following chemotherapy sessions after failed prophylactic treatment by antiemetics. CINV as the most distressing adverse effect of chemotherapy, is one of the main factor for the discontinuation of the chemotherapy cycle. Even after significant progression in the anti-emetics drug research, CINV remains the most concerned adverse event of the treatment cycle.

Read the Comprehensive Overview of Chemotherapy-induced Nausea and Vomiting (CINV) TreatmentS Market: http://www.transparencymarketresearch.com/chemotherapy-induced-nausea-vomiting-treatments-market.html

Complete understanding of the pathophysiology of CINV is yet to be achieved. However, Chemotrigger Zone and Gastrointestinal tract are two pathways which are anticipated to be involved with nausea and vomiting in chemotherapy. Chemotherapy triggers vomiting through the release of neurotransmitters serotonin, substance P, and dopamine. Advancements in research and development of medications have contributed to a number of effective agents available to manage CINV. The primary objective of antiemetic drugs is the total prevention of CINV in maximum number of patients administering chemotherapy agents.

Rising number of patients undergoing chemotherapy and increasing compliance to chemotherapy drugs due to varied treatment options such as transdermal patches and combination therapies are drivers propelling the growth of the CINV treatment market. Further, influenced by the new technology to discover highly potential newer drugs is generating opportunity for the growth of the CINV treatment market. Pharmaceutical companies are focusing on opportunities to expand their market presence and product portfolio by implementing growth strategies such as alliances and acquisitions. Increase in the investment by pharmaceutical companies in R&D of CINV treatment drugs with enhanced abilities for larger market share is the growing trend for this market. Advanced technologies in the administration of drugs such as needle free, cost-effective, and painless transdermal patches are projected to support the growth of the market.

The availability of a range of non-drugs and drug treatment options helps with the easy management of CINV. The choice of the drugs used to prevent CINV is mainly based on the type of chemotherapy agents used and its vomiting inducing ability. The non-drug treatment is mostly used for anticipatory nausea and vomiting.

On the basis of receptor antagonist, the market is segmented into serotonin receptor antagonists (5-HT3RAs), which block the serotonin receptor; neurokinin-1 receptor antagonists, which block the substance P receptor and corticosteroids. These drugs are used in combination or as single agent depending on the type of CINV. Additional clinical benefits were observed with the use of newer drugs, including palonosetron a second-generation 5-HT3 receptor antagonist and aprepitant NK-1 antagonist to manage moderate to high emetogenic effect. Cannabinoids and benzodiazepines are few other potentially effective drugs. In spite of all these an extensive continuous research with newer drugs and their combinations is required for CINV drugs.

Based on geography, the CINV market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America would dominate the market and according to the annual report by American Cancer Society approximately 1.6 million population would be effected by cancer in U.S in the year 2017 and thus it would occupy the largest market share for CINV treatment market. The Asia Pacific market is also expected to grow at a considerable rate in the near future owing to a significant rise in cancer patients and increase in the use of chemotherapy drugs. Other factors such as increased expenditure on health care infrastructure are contributing to the growth of the global market.

Some of the key participants operating in the CINV treatment market are Heron Therapeutics, Inc., Merck & Co, Inc., GlaxoSmithKline plc, Helsinn Holding S.A., and Tesaro, Inc.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25301

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Healthcare Automation Market: Smarter Technologies Up the Game for Automated Solutions

Global Healthcare Automation Market: Scope

This report offers calculated analysis of the global healthcare automation market, and the market growth forecast for 2017 to 2025. Competitive analysis of numerous market splits based on the application and end use of the market across different regional segments are covered in the scope of the report.

Read the Comprehensive Overview of Healthcare Automation Market: http://www.transparencymarketresearch.com/healthcare-automation-market.html

Increasing demand for Internet of Things is an important trend in the global healthcare automation market. With the help of this technology, gathering medical data of patients easily accessible. Moreover, it helps in improving the health by increasing its quality and availability of care and also decreases the costs. Additionally, this technology helps in remote monitoring and clinical care. Demand for wearable technology is increasing rapidly and is an important trend in the global market. Wearable technology is employed for collecting real-time data, continuous monitoring, empowering patients, and predicting and alerting patients about their health. Furthermore, wearable technology helps in tracking surgical recovery that is likely to present more detailed information to doctors and better understand patients’ recovery time.

Global Healthcare Automation Market: Trends and Opportunities

Implementation of automation is anticipated to reduce the amount of labor intensive tasks such as lab tests and clinical diagnostics, thereby helping hospitals or clinics to save costs pertaining to the processes. Automation allows medical individuals to carry out other important tasks since it helps in performing repetitive tasks. This is estimated to help in carrying out the tasks efficiently. These technologies are employed to carry out different critical tasks that need accuracy and can be accomplished through automated machines, which again indicates reduction of overhead counts.

Moreover, automation decreases wastage of time as compared to manual labor. This factor is likely to have a medium impact during the short-term period. Increasing government investment is an important factor propelling the global market during the forecast period. Usage of smart technology in the market is propelling the demand for healthcare automation. Currently, the government is supporting implementation of automation in healthcare by providing funds and investments in the healthcare industries.

For instance, in Europe, government bodies, such as Medicines and Healthcare Products Regulatory Agency, are endorsing automated system for pharmacies. Government authorities are investing funds in research and development assisting innovation in the healthcare automation sector. Rising health issues is a major concern, globally, so to overcome such issues newer types of automation technologies have to be implemented in the healthcare automation section. Rising advancement in technology is another driving factor in this market. Technological advancement helps in developing energy efficient technologies that are likely to help in real-time data collection, continuous monitoring, predicting and alerting the increasing risk of possibly serious health issue, and alert the healthcare providers that an interference is required.

Global Healthcare Automation Market: Segmentation

The global healthcare automation market is bifurcated on the basis of application into therapeutic automation, lab and pharmacy automation, logistics and training automation and diagnostics and monitoring automation. In 2016, therapeutic automation market accounted for the highest market revenue share. Need for accuracy and rising cost of labor are some of the major factors bolstering the demand of this segment globally during the forecast period. Moreover, on the basis of end use the market is bifurcated into pharmacies, research institutes and labs, home care and others. Research institutes and labs held the highest market revenue globally during the forecast period. The geographical split of the global market encompasses North America, Europe, Asia Pacific, Middle East and Africa and Latin America. North America holds the highest market share followed by Europe and Asia Pacific in 2016.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23888

Key Players Mentioned in the Report are:

Some of the principal players in the global healthcare automation market are Siemens AG (Germany), General Electric Company (U.S.), Swisslog Holding AG (Switzerland), Koninklijke Philips N.V. (the Netherlands), Medtronic PLC (Ireland), Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Danaher Corporation (U.S.), Accuray Inc. (U.S.) and Tecan Group Ltd. (Switzerland) among others.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Healthcare M2M Market to Rise at 22.5% by 2023 due to Increasing Demand for Wearable Technology

Machine-to-machine (M2M) technologies establish a connection between wired and wireless devices and equipment through a wired line, Wi-Fi, Bluetooth, RFID, LAN, and other related technologies. The introduction and usage of M2M in the healthcare sector has breathed life into traditional practices of patient care. The increasing awareness of wearable devices that have integrated M2M applications to keep a track of fitness regimes and activities such as stress, sleep, and calorie intake is also changing the face of healthcare. The growing demand for real-time care is likely to fuel the growth of the global healthcare M2M market in the coming years.

Read the Comprehensive Overview of Healthcare M2M Market: http://www.transparencymarketresearch.com/healthcare-m2m-market.html

The global healthcare M2M market is segmented on the basis of the component, application, and geography. The components that constitute this market are M2M modules, M2M applications and platforms, and connectivity services. The applications of healthcare M2M are seen in patient well-being, sports and fitness, medical facilities, and others such as implants and research and foundation. Geographically, this market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

As of 2014, North America held a share of about 34% in the global healthcare M2M market. Research indicates that the increasing deployment of healthcare M2M in the healthcare sector of North America has helped in ironing out the issues of demand and supply of patient-centric healthcare in several cities in the region along with bringing in renewed productivity. The demand for healthcare M2M solutions will continue to remain high in North America due to the high incidence of chronic diseases and a rising pool of geriatrics.

Between 2015 and 2022, the Asia Pacific region will also show significant progress surging at a CAGR of 26.9%. The growth of the healthcare M2M market in this region will be a result of the increasing M2M-based connections, rising government initiatives to improve the healthcare infrastructure, and a high demand for low-cost medical connectivity services.

Some of the important players operating in the global healthcare M2M market are GE Healthcare, Athenahealth, Inc., IBM Corporation, Apple Inc., Allscripts Healthcare Solutions Inc., Stanley Healthcare, AT&T Inc., Gemalto NV, Sierra Wireless Inc., and Cisco Systems Inc. The research report provides a thorough analysis of the market by profiling these vendors and explaining the competitive landscape. Furthermore, the report also provides an evaluation of the research and development strategies, financial overview, investment outlook, business and marketing strategies, and expansion plans of these players for the coming few years.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8590

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/